Vickyb Gregg News Today

Quest Diagnostics Incorporated (NYSE:DGX – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as $145.62 and last traded at $145.34, with a volume of 265199 shares changing hands. The stock had previously closed at $144.34. Wall Street Analyst Weigh In A number of […]

Arjuna Capital cut its position in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 87.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,682 shares of the medical research company’s stock after selling 11,381 shares during the quarter. […]

StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a research report released on Friday. Other research analysts also recently issued research reports about the stock. Truist Financial increased their price objective on shares of Quest Diagnostics from $145.00 to $150.00 and gave the company […]

Golden State Equity Partners boosted its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 14.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,035 shares of the medical research company’s stock after acquiring an additional 251 shares during the […]

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective increased by equities researchers at Barclays from $138.00 to $144.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 7.25% from the company’s […]

Bahl & Gaynor Inc. lifted its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 212,951 shares of the medical research company’s stock after buying an additional 29,469 shares during […]

Motley Fool Asset Management LLC reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. Motley Fool Asset […]

Cwm LLC increased its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 1.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,200 shares of the medical research company’s stock after purchasing an additional 232 shares during the period. […]

Quest Diagnostics (NYSE:DGX – Free Report) had its price objective increased by Barclays from $138.00 to $144.00 in a report released on Thursday morning, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other brokerages have also issued reports on DGX. StockNews.com raised shares of Quest Diagnostics from […]

Quest Diagnostics (NYSE:DGX – Get Free Report) issued its quarterly earnings data on Tuesday. The medical research company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.18, Briefing.com reports. The business had revenue of $2.37 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Quest […]